AVM embolization treatment details
| Patient no | Number of embolization sessions | Number of arterial pedicles | Arterial pedicles embolized | n-BCA dilutions* | Post-embolization complications |
|---|---|---|---|---|---|
| 1 | 3 | 3 | Anterior choroidal×3 | 1:3 1:3.5 | None |
| 2 | 4 | 6 | MCA×2 PCA×4 | 1:2 1:2.5 1:3 | None |
| 3 | 4 | 6 | MCA×1 PCA×3 ACA×2 | 1:2.5 1:2.75 1:3 | None |
| 4 | 4 | 6 | MCA×5 ACA×1 | 1:1.5 1:1.75 1:2 1:2.5 1:3 | None |
| 5 | 5 | 9 | PICA×3 SCA×6 | 1:2.5 1:3 | Hemorrhage |
| 6 | 1 | 1 | PCA×1 | 1:2 | None |
| 7 | 1 | 1 | Middle meningeal | 1:2 | None |
| 8 | 4 | 8 | Posterior choroidal×7 Inferolateral×1 | 1:2.5 1:3 | None |
| 9 | 2 | 3 | MCA×3 | 1:03 | None |
| 10 | 4 | 7 | ACA×2 MCA×1 PCA×4 Inferolateral×1 | 1:1 1:0.75 1:1.5 1:2 1:2.75 | None |
*Denoted as n-BCA:ethiodol ratio.
ACA, anterior cerebral artery; AVM, arteriovenous malformation; MCA, middle cerebral artery; n-BCA, n-butyl-cyanoacrylate; PCA, posterior cerebral artery; PICA, posterior inferior cerebellar artery; SCA, superior cerebellar artery.